Nat Cell Biol:miR-675调控胎盘的生长

2012-06-17 Beyond 生物谷

近日,Babraham研究所的科学家们对胎儿出生前胎盘的生长情况已经获得了新的认识,这对健康怀孕有重要意义。研究结果发表在6月10日的Nature Cell Biology杂志上,研究证实miR-675在胎儿出生前能使得胎盘的生长速度变慢。 RNA分子是细胞DNA和细胞功能所必需的物质中介,Babraham研究所的科学家们正在研究这些非编码RNA包括小分子RNA(短的非编码RNA分子类型)是如何

近日,Babraham研究所的科学家们对胎儿出生前胎盘的生长情况已经获得了新的认识,这对健康怀孕有重要意义。研究结果发表在6月10日的Nature Cell Biology杂志上,研究证实miR-675在胎儿出生前能使得胎盘的生长速度变慢。

RNA分子是细胞DNA和细胞功能所必需的物质中介,Babraham研究所的科学家们正在研究这些非编码RNA包括小分子RNA(短的非编码RNA分子类型)是如何调节细胞的发育和功能的。

非编码RNA H19的是在哺乳动物中发现的最多的RNA分子之一,但到现在为止,它的功能却是未知的。在这项研究中,研究人员首次表明RNA H19的一种miR-675能限制胎盘的生长。

Babraham研究所Andrew Keniry博士解释说, miR-675的释放由一种应激反应蛋白控制,提示这可能是胚胎发育机制过程中调控胚胎在子宫内生长的关键所在。(生物谷:Bioon.com)

doi:10.1038/ncb2521
PMC:
PMID:

The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r

Andrew Keniry,David Oxley,Paul Monnier,Michael Kyba,Luisa Dandolo,Guillaume Smits& Wolf Reik

The H19 large intergenic non-coding RNA (lincRNA) is one of the most highly abundant and conserved transcripts in mammalian development, being expressed in both embryonic and extra-embryonic cell lineages, yet its physiological function is unknown. Here we show that miR-675, a microRNA (miRNA) embedded in H19’s first exon, is expressed exclusively in the placenta from the gestational time point when placental growth normally ceases, and placentas that lack H19 continue to grow. Overexpression of miR-675 in a range of embryonic and extra-embryonic cell lines results in their reduced proliferation; targets of the miRNA are upregulated in the H19 null placenta, including the growth-promoting insulin-like growth factor 1 receptor (Igf1r) gene. Moreover, the excision of miR-675 from H19 is dynamically regulated by the stress-response RNA-binding protein HuR. These results suggest that H19’s main physiological role is in limiting growth of the placenta before birth, by regulated processing of miR-675. The controlled release of miR-675 from H19 may also allow rapid inhibition of cell proliferation in response to cellular stress or oncogenic signals.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1879277, encodeId=def918e9277ba, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Oct 12 23:06:00 CST 2012, time=2012-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916899, encodeId=7828191689965, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Mar 01 03:06:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958757, encodeId=31501958e5740, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon May 27 03:06:00 CST 2013, time=2013-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766788, encodeId=40031e66788fd, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Dec 28 21:06:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930353, encodeId=51821930353fe, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sat Oct 27 11:06:00 CST 2012, time=2012-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868525, encodeId=6137186852585, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Apr 08 11:06:00 CST 2013, time=2013-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406797, encodeId=498d1406e9765, content=<a href='/topic/show?id=2aca8365e2c' target=_blank style='color:#2F92EE;'>#胎盘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83657, encryptionId=2aca8365e2c, topicName=胎盘)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItxfbnwF4Yku2j227me6wl2EGarBoTicR3tHxrMtib5tnyyEEsgxlHkk8JAS4ZjHsEF7PxhBwh1QwQ/132, createdBy=c8162575557, createdName=liuyong2981, createdTime=Tue Jun 19 11:06:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
    2012-10-12 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1879277, encodeId=def918e9277ba, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Oct 12 23:06:00 CST 2012, time=2012-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916899, encodeId=7828191689965, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Mar 01 03:06:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958757, encodeId=31501958e5740, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon May 27 03:06:00 CST 2013, time=2013-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766788, encodeId=40031e66788fd, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Dec 28 21:06:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930353, encodeId=51821930353fe, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sat Oct 27 11:06:00 CST 2012, time=2012-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868525, encodeId=6137186852585, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Apr 08 11:06:00 CST 2013, time=2013-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406797, encodeId=498d1406e9765, content=<a href='/topic/show?id=2aca8365e2c' target=_blank style='color:#2F92EE;'>#胎盘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83657, encryptionId=2aca8365e2c, topicName=胎盘)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItxfbnwF4Yku2j227me6wl2EGarBoTicR3tHxrMtib5tnyyEEsgxlHkk8JAS4ZjHsEF7PxhBwh1QwQ/132, createdBy=c8162575557, createdName=liuyong2981, createdTime=Tue Jun 19 11:06:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
    2013-03-01 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1879277, encodeId=def918e9277ba, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Oct 12 23:06:00 CST 2012, time=2012-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916899, encodeId=7828191689965, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Mar 01 03:06:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958757, encodeId=31501958e5740, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon May 27 03:06:00 CST 2013, time=2013-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766788, encodeId=40031e66788fd, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Dec 28 21:06:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930353, encodeId=51821930353fe, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sat Oct 27 11:06:00 CST 2012, time=2012-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868525, encodeId=6137186852585, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Apr 08 11:06:00 CST 2013, time=2013-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406797, encodeId=498d1406e9765, content=<a href='/topic/show?id=2aca8365e2c' target=_blank style='color:#2F92EE;'>#胎盘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83657, encryptionId=2aca8365e2c, topicName=胎盘)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItxfbnwF4Yku2j227me6wl2EGarBoTicR3tHxrMtib5tnyyEEsgxlHkk8JAS4ZjHsEF7PxhBwh1QwQ/132, createdBy=c8162575557, createdName=liuyong2981, createdTime=Tue Jun 19 11:06:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
    2013-05-27 维他命
  4. [GetPortalCommentsPageByObjectIdResponse(id=1879277, encodeId=def918e9277ba, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Oct 12 23:06:00 CST 2012, time=2012-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916899, encodeId=7828191689965, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Mar 01 03:06:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958757, encodeId=31501958e5740, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon May 27 03:06:00 CST 2013, time=2013-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766788, encodeId=40031e66788fd, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Dec 28 21:06:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930353, encodeId=51821930353fe, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sat Oct 27 11:06:00 CST 2012, time=2012-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868525, encodeId=6137186852585, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Apr 08 11:06:00 CST 2013, time=2013-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406797, encodeId=498d1406e9765, content=<a href='/topic/show?id=2aca8365e2c' target=_blank style='color:#2F92EE;'>#胎盘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83657, encryptionId=2aca8365e2c, topicName=胎盘)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItxfbnwF4Yku2j227me6wl2EGarBoTicR3tHxrMtib5tnyyEEsgxlHkk8JAS4ZjHsEF7PxhBwh1QwQ/132, createdBy=c8162575557, createdName=liuyong2981, createdTime=Tue Jun 19 11:06:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1879277, encodeId=def918e9277ba, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Oct 12 23:06:00 CST 2012, time=2012-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916899, encodeId=7828191689965, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Mar 01 03:06:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958757, encodeId=31501958e5740, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon May 27 03:06:00 CST 2013, time=2013-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766788, encodeId=40031e66788fd, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Dec 28 21:06:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930353, encodeId=51821930353fe, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sat Oct 27 11:06:00 CST 2012, time=2012-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868525, encodeId=6137186852585, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Apr 08 11:06:00 CST 2013, time=2013-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406797, encodeId=498d1406e9765, content=<a href='/topic/show?id=2aca8365e2c' target=_blank style='color:#2F92EE;'>#胎盘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83657, encryptionId=2aca8365e2c, topicName=胎盘)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItxfbnwF4Yku2j227me6wl2EGarBoTicR3tHxrMtib5tnyyEEsgxlHkk8JAS4ZjHsEF7PxhBwh1QwQ/132, createdBy=c8162575557, createdName=liuyong2981, createdTime=Tue Jun 19 11:06:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
    2012-10-27 smallant2002
  6. [GetPortalCommentsPageByObjectIdResponse(id=1879277, encodeId=def918e9277ba, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Oct 12 23:06:00 CST 2012, time=2012-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916899, encodeId=7828191689965, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Mar 01 03:06:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958757, encodeId=31501958e5740, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon May 27 03:06:00 CST 2013, time=2013-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766788, encodeId=40031e66788fd, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Dec 28 21:06:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930353, encodeId=51821930353fe, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sat Oct 27 11:06:00 CST 2012, time=2012-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868525, encodeId=6137186852585, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Apr 08 11:06:00 CST 2013, time=2013-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406797, encodeId=498d1406e9765, content=<a href='/topic/show?id=2aca8365e2c' target=_blank style='color:#2F92EE;'>#胎盘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83657, encryptionId=2aca8365e2c, topicName=胎盘)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItxfbnwF4Yku2j227me6wl2EGarBoTicR3tHxrMtib5tnyyEEsgxlHkk8JAS4ZjHsEF7PxhBwh1QwQ/132, createdBy=c8162575557, createdName=liuyong2981, createdTime=Tue Jun 19 11:06:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1879277, encodeId=def918e9277ba, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Oct 12 23:06:00 CST 2012, time=2012-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916899, encodeId=7828191689965, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Fri Mar 01 03:06:00 CST 2013, time=2013-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1958757, encodeId=31501958e5740, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon May 27 03:06:00 CST 2013, time=2013-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766788, encodeId=40031e66788fd, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Fri Dec 28 21:06:00 CST 2012, time=2012-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1930353, encodeId=51821930353fe, content=<a href='/topic/show?id=22f61180211' target=_blank style='color:#2F92EE;'>#miR#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11802, encryptionId=22f61180211, topicName=miR)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Sat Oct 27 11:06:00 CST 2012, time=2012-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868525, encodeId=6137186852585, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Apr 08 11:06:00 CST 2013, time=2013-04-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406797, encodeId=498d1406e9765, content=<a href='/topic/show?id=2aca8365e2c' target=_blank style='color:#2F92EE;'>#胎盘#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83657, encryptionId=2aca8365e2c, topicName=胎盘)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTItxfbnwF4Yku2j227me6wl2EGarBoTicR3tHxrMtib5tnyyEEsgxlHkk8JAS4ZjHsEF7PxhBwh1QwQ/132, createdBy=c8162575557, createdName=liuyong2981, createdTime=Tue Jun 19 11:06:00 CST 2012, time=2012-06-19, status=1, ipAttribution=)]

相关资讯

Biol Psychiat:D-环丝氨酸有助治疗创伤后应激障碍

近日,科学家们发现D-环丝氨酸能加强现有的创伤后应激障碍的治疗方法的治疗功效,新的研究报告发表在Biological Psychiatry杂志上。 创伤后应激障碍(PTSD)是最常见的生活事件。创伤后应激障碍的第一线治疗是暴露疗法,就是让病人在一个安全的环境面对他们的恐惧。虽然这是一种有效的治疗,但仍然会出现许多治疗后的症状,因此其成功率并不高。 在努力改进现有的治疗方法的基础上,本周发表在B

PLoS Comput Biol:艾滋病毒耐药性的起源问题

近日,哈佛大学的科学家们发现在少数艾滋病患者预先存在的突变可能导致病毒产生耐药性。这一发现特别重要,因为虽然研究人员早就知道艾滋病毒可以对某些药物产生耐药性,但我们一直不理解该病毒是否靠预先已经存在的突变来产生耐药性,相关研究论文发表在PLoS Computational Biology杂志上。 Pennings收集了26个临床试验的数据收集。这些患者接受NNRTI药物的治疗以阻止病毒的繁殖。然

Cell Stem Cell:p53/p21在范可尼氏贫血病中的独特作用

6月7日,Cell Stem Cell杂志在线报道了,p53/p21在范可尼氏贫血中发挥的独特作用。 范可尼氏贫血(FA)是一种遗传性DNA修复缺陷综合征。FA患者常在童年期发生进行性骨髓功能失调(BMF),需要进行同种异体造血干细胞移植。这种BMF的病理机制至今不明。 该研究表明,FA患者的造血干细胞和造血祖细胞(HSPCs)在发生BMF之前就已经显示出严重的缺陷。由于复制的压力和DNA损伤

PNAS:寒冷可以激活棕色脂肪燃烧 为减肥提供良机

棕色脂肪 近日,来自乔斯林糖尿病中心的研究者通过研究发现,一种对人体有益处的脂肪会在低温下被激活,研究者们同时也发现这种脂肪并不会被药物麻黄碱所激活。相关研究成果刊登在了近日的国际杂志PNAS上。文章中所提到的这种脂肪是棕色脂肪,这种脂肪一旦激活,可以在机体内燃烧卡路里并且帮助机体抵御肥胖。 研究者Aaron Cypess表示,我们可以通过提供类似制冷的因子来激活棕色脂肪,进而寻找到抵御肥胖的

Nature:哺乳动物细胞的生物计算器开发为病人带来福利

研究者重新编程了哺乳动物的细胞以便像袖珍计算机一样使细胞执行逻辑运算的能力。 (Credit: J. Kuster / ETH Zurich) 近日,来自苏黎世联邦理工学院的研究者重新编程了哺乳动物的细胞以便像袖珍计算机一样使细胞执行逻辑运算的能力。这些细胞欠缺一种最为复杂的基因调控网络,于是研究者构架了不同的基因调控网络使其可以进行运算,基于此,细胞可以进行特殊的代谢过程。科学家用生物组分开发

FASEB J:研究人员发现大脑调节肾功能的信号

近日,波士顿大学医学院(BUSM)的研究人员发现大脑中调节肾脏排泄钠的信号通路。这一发现刊登在Journal of the Federation of American Societies for Experimental Biology杂志上。   高血压或慢性血压高,影响了三分之一的成年人,能显着增加心血管疾病的风险和死亡率。高血压患者中约50%是对盐敏感的,表现为盐摄入后血压会